Adenosine is a ubiquitous nucleoside in almost all the cells throughout our bodies. It is highly induced particularly under hypoxia or energy depletion conditions. Adenosine functions as a critical ligand, after binding to membrane-associated adenosine receptors, adenosine initiates a downstream signaling cascade and subsequently contributes to functions of nervous system, immune response, vascular function and even metabolism.
Hypoxia is a condition with limited O2 availability in the whole body or a region of the body. It is a major consequence of many respiratory and cardiovascular diseases, as well as for people living and working at high altitudes or other low O2 conditions. Without intervention, it can progress to pulmonary and cerebral edema, stroke, cardiovascular dysfunction and death. Although hypoxia-induced tissue damage is a serious condition with high morbidity and mortality, safe and effective mechanism-based therapies are limited.
The erythrocyte is the most abundant circulating cell type and functions as the only cell-type responsible for O2 availability in peripheral tissues. Its fundamental function, O2 release capacity and O2 delivery capacity, is determined by hemoglobin-O2 binding affinity and cell number, respectively.
Although adenosine signaling is beneficial under stress conditions in various organs and tissues via activation of different adenosine receptors, its significance and functional role in the erythroid lineage, particularly under stress conditions, are still unclear.
My dissertation employing multi-disciplinary approaches including human studies, novel genetic tools, and sophisticated pharmacological studies coupled with metabolomic profiling shows for the first time that 1) CD73-dependent elevation of plasma adenosine signaling via erythrocyte specific ADORA2B coupled with AMP-activated protein kinase is a key mechanism for hypoxia adaptation via induction of 2,3-BPG production with O2 release to counteract severe hypoxia. 2) Adenosine signaling via erythroid ADORA2B is a previously unrecognized purinergic signaling responsible for stress erythropoiesis by regulation of erythroid commitment in a hypoxia-inducible factor 1-alpha dependent manner.
Thus, my research has identified that adenosine signaling functions as a novel molecular mechanism involved in the regulation of erythrocyte O2 release capacity and O2 delivery capacity, providing therapeutic possibilities to enhance O2 availability and prevent stress-induced tissue damage and inflammation, a strong foundation for future clinical trials to treat diseases associated with hypoxia or hematology disorders provided by my doctoral work.
","abstract_html":"<p>Adenosine is a ubiquitous nucleoside in almost all the cells throughout our bodies. It is highly induced particularly under hypoxia or energy depletion conditions. Adenosine functions as a critical ligand, after binding to membrane-associated adenosine receptors, adenosine initiates a downstream signaling cascade and subsequently contributes to functions of nervous system, immune response, vascular function and even metabolism.</p> <p>Hypoxia is a condition with limited O<sub>2</sub> availability in the whole body or a region of the body. It is a major consequence of many respiratory and cardiovascular diseases, as well as for people living and working at high altitudes or other low O<sub>2</sub> conditions. Without intervention, it can progress to pulmonary and cerebral edema, stroke, cardiovascular dysfunction and death. Although hypoxia-induced tissue damage is a serious condition with high morbidity and mortality, safe and effective mechanism-based therapies are limited.</p> <p>The erythrocyte is the most abundant circulating cell type and functions as the only cell-type responsible for O<sub>2</sub> availability in peripheral tissues. Its fundamental function, O<sub>2</sub> release capacity and O<sub>2</sub> delivery capacity, is determined by hemoglobin-O<sub>2</sub> binding affinity and cell number, respectively.</p> <p>Although adenosine signaling is beneficial under stress conditions in various organs and tissues via activation of different adenosine receptors, its significance and functional role in the erythroid lineage, particularly under stress conditions, are still unclear.</p> <p>My dissertation employing multi-disciplinary approaches including human studies, novel genetic tools, and sophisticated pharmacological studies coupled with metabolomic profiling shows for the first time that 1) CD73-dependent elevation of plasma adenosine signaling via erythrocyte specific ADORA2B coupled with AMP-activated protein kinase is a key mechanism for hypoxia adaptation via induction of 2,3-BPG production with O<sub>2</sub> release to counteract severe hypoxia. 2) Adenosine signaling via erythroid ADORA2B is a previously unrecognized purinergic signaling responsible for stress erythropoiesis by regulation of erythroid commitment in a hypoxia-inducible factor 1-alpha dependent manner.</p> <p>Thus, my research has identified that adenosine signaling functions as a novel molecular mechanism involved in the regulation of erythrocyte O<sub>2</sub> release capacity and O<sub>2</sub> delivery capacity, providing therapeutic possibilities to enhance O<sub>2</sub> availability and prevent stress-induced tissue damage and inflammation, a strong foundation for future clinical trials to treat diseases associated with hypoxia or hematology disorders provided by my doctoral work.</p>","abstract_has_math":false,"creators":["Liu, Hong","orcid.org/0000-0001-9976-2985
"],"institution":null,"degree_name":"Doctor of Philosophy (PhD)","degree_level":"Dissertation (PhD)","degree_discipline":null,"degree_department":null,"school":null,"contributors":["Yang Xia, M.D., Ph.D.","Rodney Kellems, Ph.D.","Chengchi Lee, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-05-01T07:00:00Z","date_published":"2017-05-01T07:00:00Z","updated_at":"2026-07-24T05:49:41Z","subjects":["Hypoxia","adenosine signaling","metabolomics","erythroid progenitors","stress erythropiesis","high altitude","erythrocyte","Biochemistry","Cell Biology","Life Sciences","Medicine and Health Sciences","Molecular Biology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/777","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Yang Xia, M.D., Ph.D.","Rodney Kellems, Ph.D.","Chengchi Lee, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Liu, Hong","orcid.org/0000-0001-9976-2985
"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2018-05-25T07:00:00Z"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation (PhD)"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Hypoxia","adenosine signaling","metabolomics","erythroid progenitors","stress erythropiesis","high altitude","erythrocyte","Biochemistry","Cell Biology","Life Sciences","Medicine and Health Sciences","Molecular Biology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.library.tmc.edu/utgsbs_dissertations/777"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Adenosine is a ubiquitous nucleoside in almost all the cells throughout our bodies. It is highly induced particularly under hypoxia or energy depletion conditions. Adenosine functions as a critical ligand, after binding to membrane-associated adenosine receptors, adenosine initiates a downstream signaling cascade and subsequently contributes to functions of nervous system, immune response, vascular function and even metabolism.
Hypoxia is a condition with limited O2 availability in the whole body or a region of the body. It is a major consequence of many respiratory and cardiovascular diseases, as well as for people living and working at high altitudes or other low O2 conditions. Without intervention, it can progress to pulmonary and cerebral edema, stroke, cardiovascular dysfunction and death. Although hypoxia-induced tissue damage is a serious condition with high morbidity and mortality, safe and effective mechanism-based therapies are limited.
The erythrocyte is the most abundant circulating cell type and functions as the only cell-type responsible for O2 availability in peripheral tissues. Its fundamental function, O2 release capacity and O2 delivery capacity, is determined by hemoglobin-O2 binding affinity and cell number, respectively.
Although adenosine signaling is beneficial under stress conditions in various organs and tissues via activation of different adenosine receptors, its significance and functional role in the erythroid lineage, particularly under stress conditions, are still unclear.
My dissertation employing multi-disciplinary approaches including human studies, novel genetic tools, and sophisticated pharmacological studies coupled with metabolomic profiling shows for the first time that 1) CD73-dependent elevation of plasma adenosine signaling via erythrocyte specific ADORA2B coupled with AMP-activated protein kinase is a key mechanism for hypoxia adaptation via induction of 2,3-BPG production with O2 release to counteract severe hypoxia. 2) Adenosine signaling via erythroid ADORA2B is a previously unrecognized purinergic signaling responsible for stress erythropoiesis by regulation of erythroid commitment in a hypoxia-inducible factor 1-alpha dependent manner.
Thus, my research has identified that adenosine signaling functions as a novel molecular mechanism involved in the regulation of erythrocyte O2 release capacity and O2 delivery capacity, providing therapeutic possibilities to enhance O2 availability and prevent stress-induced tissue damage and inflammation, a strong foundation for future clinical trials to treat diseases associated with hypoxia or hematology disorders provided by my doctoral work.
"]},{"key":"dc:title","label":"Title","values":["The Role of Adenosine Signaling In Mature Erythrocytes and Erythroid Progenitors"]}]}],"canonical_facts":{"dc:contributor":["Yang Xia, M.D., Ph.D.","Rodney Kellems, Ph.D.","Chengchi Lee, Ph.D."],"dc:creator":["Liu, Hong","orcid.org/0000-0001-9976-2985
"],"dc:date.available":["2018-05-25T07:00:00Z"],"dc:description.abstract":["Adenosine is a ubiquitous nucleoside in almost all the cells throughout our bodies. It is highly induced particularly under hypoxia or energy depletion conditions. Adenosine functions as a critical ligand, after binding to membrane-associated adenosine receptors, adenosine initiates a downstream signaling cascade and subsequently contributes to functions of nervous system, immune response, vascular function and even metabolism.
Hypoxia is a condition with limited O2 availability in the whole body or a region of the body. It is a major consequence of many respiratory and cardiovascular diseases, as well as for people living and working at high altitudes or other low O2 conditions. Without intervention, it can progress to pulmonary and cerebral edema, stroke, cardiovascular dysfunction and death. Although hypoxia-induced tissue damage is a serious condition with high morbidity and mortality, safe and effective mechanism-based therapies are limited.
The erythrocyte is the most abundant circulating cell type and functions as the only cell-type responsible for O2 availability in peripheral tissues. Its fundamental function, O2 release capacity and O2 delivery capacity, is determined by hemoglobin-O2 binding affinity and cell number, respectively.
Although adenosine signaling is beneficial under stress conditions in various organs and tissues via activation of different adenosine receptors, its significance and functional role in the erythroid lineage, particularly under stress conditions, are still unclear.
My dissertation employing multi-disciplinary approaches including human studies, novel genetic tools, and sophisticated pharmacological studies coupled with metabolomic profiling shows for the first time that 1) CD73-dependent elevation of plasma adenosine signaling via erythrocyte specific ADORA2B coupled with AMP-activated protein kinase is a key mechanism for hypoxia adaptation via induction of 2,3-BPG production with O2 release to counteract severe hypoxia. 2) Adenosine signaling via erythroid ADORA2B is a previously unrecognized purinergic signaling responsible for stress erythropoiesis by regulation of erythroid commitment in a hypoxia-inducible factor 1-alpha dependent manner.
Thus, my research has identified that adenosine signaling functions as a novel molecular mechanism involved in the regulation of erythrocyte O2 release capacity and O2 delivery capacity, providing therapeutic possibilities to enhance O2 availability and prevent stress-induced tissue damage and inflammation, a strong foundation for future clinical trials to treat diseases associated with hypoxia or hematology disorders provided by my doctoral work.
"],"dc:identifier":["https://digitalcommons.library.tmc.edu/utgsbs_dissertations/777"],"dc:subject":["Hypoxia","adenosine signaling","metabolomics","erythroid progenitors","stress erythropiesis","high altitude","erythrocyte","Biochemistry","Cell Biology","Life Sciences","Medicine and Health Sciences","Molecular Biology"],"dc:title":["The Role of Adenosine Signaling In Mature Erythrocytes and Erythroid Progenitors"],"thesis:degree_level":["Dissertation (PhD)"],"thesis:degree_name":["Doctor of Philosophy (PhD)"]},"updated_at":"2026-07-24T05:49:41Z"}